Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/39891

Title:	Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.
Authors:	Hochhaus, Andreas Mahon, Franҫois-Xavier le Coutre, Philipp Petrov, Ljubomir Janssen, Jeroen J W M Cross, Nicholas C P Rea, Delphine Castagnetti, Fausto Hellmann, Andrzej Rosti, Gianantonio Gattermann, Norbert Coronel, Maria Liz Paciello Gutierrez, Maria Asuncion Echeveste Garcia-Gutierrez, Valentin Vincenzi, Beatrice Dezzani, Luca Giles, Francis J View more
Keywords:	Chronic myeloid leukemia ENEST1st Nilotinib Philadelphia chromosome negative/BCR-ABL positive View more
Mesh:	Adolescent Adult Aged Antineoplastic Agents Female Fusion Proteins, bcr-abl Humans Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Male Middle Aged Multiplex Polymerase Chain Reaction Philadelphia Chromosome Protein Kinase Inhibitors Pyrimidines Real-Time Polymerase Chain Reaction Young Adult View more
Issue Date:	Jul-2017
Citation:	J. Cancer Res. Clin. Oncol..2017 Jul;(143)7:1225-1233
Abstract:	The ENEST1st sub-analysis presents data based on Philadelphia chromosome (Ph) status, i.e., Ph+ and Ph-/BCR-ABL1 + chronic myeloid leukemia.
PMID:	28224300
URI:	https://hdl.handle.net/20.500.12530/39891
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:

File	Description	Size	Format
PMC5486575.pdf		994.9 kB	Adobe PDF	View/Open